Clinical trial
A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen…
NCT00152295 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00152295 |
|---|---|
| Title | A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administration to Postmenopausal Women |
| Official title | A Phase II Long-Term Extension Safety Study of J867 Administered With Estrogen to Postmenopausal Women |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Postmenopause |
| Intervention type | Drug |
| Interventions | Asoprisnil/Premarin |
| Enrollment | 18 |
| Start date | Apr 1, 2001 |
| Primary completion | Dec 1, 2001 |
| Completion | Dec 1, 2001 |
| First posted | Sep 9, 2005 |
| Last update posted | May 29, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: